United Kingdom Renal Denervation Market By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others), By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Regi
Published on: 2024-11-24 | No of Pages : 320 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
United Kingdom Renal Denervation Market By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others), By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Regi
United Kingdom renal denervation market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The market growth can be attributed to growing instances of hypertension. Growing complexities of the hypertension disorders and its adverse effect on the kidney functioning drives the growth of the United Kingdom renal denervation market in the upcoming five years. Growing advancement in the medical devices supportive of the renal denervation procedure also fuel the growth of the United Kingdom renal denervation market in the next five years.
minimally invasive
Surging Number of Hypertension Patients Promises Market Growth
hypertension
medical devices
Click here to download the sample
Market Segmentation
The United Kingdom renal denervation market is segmented by technology, product, therapeutic area, end user, competitional landscape, and regional distribution.
Company Profile
Medtronic United Kingdom, Boston Scientific Limited, Abbott Laboratories Limited, CardioSonic Limited, Terumo UK Limited, Johnson & Johnson Limited
| Attribute | Details |
| Base Year | 2021 |
| Historical Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Technology · Product · Therapeutic Area · End User |
| Regional scope | London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside |
| Key companies profiled | Medtronic United Kingdom, Boston Scientific Limited, Abbott Laboratories Limited, CardioSonic Limited, Terumo UK Limited, Johnson & Johnson Limited |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |